Bergstrom Donald A 4
4 · Relay Therapeutics, Inc. · Filed Apr 30, 2026
Research Summary
AI-generated summary of this filing
Relay Therapeutics R&D President Donald Bergstrom Sells Shares
What Happened
Donald A. Bergstrom, President of Research & Development at Relay Therapeutics (RLAY), disposed of 1,490 shares on 2026-04-28 at $14.79 per share for proceeds of $22,037. The filing reports this was a sale (code S) done to satisfy income tax withholding obligations related to recent RSU vesting, not an independent open‑market trade intended as an investment signal.
Key Details
- Transaction date and price: 2026-04-28, 1,490 shares sold at $14.79 each (total ≈ $22,037).
- Reason: Sale to cover tax withholding on vesting of 5,012 RSUs (vested 2026-04-27); sale was not at the reporting person's discretion and followed issuer policy (footnote F1).
- Holdings note: Form indicates "Includes 15,037 shares underlying RSUs" (footnote F2). The Form 4 does not state a different total post‑sale share count.
- Filing: Report filed 2026-04-30 for the 2026-04-28 transaction — appears to be a timely Form 4 filing.
Context
This was a routine, tax‑withholding sale following RSU vesting rather than a discretionary sell for liquidity or market-timing. Such transactions are common when restricted stock units vest; they do not necessarily indicate management sentiment about the company. Purchases generally carry more informational weight for investors than routine withholding sales.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-04-28$14.79/sh−1,490$22,037→ 418,557 total
Footnotes (2)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,012 shares of restricted stock units ("RSUs") on April 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 15,037 shares underlying RSUs.